Literature DB >> 31548218

Myeloid Cells in Metastasis.

Agnieszka Swierczak1, Jeffrey W Pollard1.   

Abstract

Metastatic disease is the leading cause of death in patients with solid cancers. The progression to metastasis is a multistep process that involves detachment of tumor cells from their constraining basement membrane at the primary site, migration and intravasation into the circulation, survival in the circulation, extravasation into the secondary organ, and survival and growth at the secondary site. During these steps, tumor and immune cells interact and influence each other both within the tumor microenvironment and systemically. In particular, myeloid cells such as monocytes, macrophages, neutrophils, and myeloid-derived suppressor cells (myeloid regulatory cells) have been shown to play important roles in the metastatic process. These interactions open new avenues for targeting cancer metastasis, especially given the increasing interest in development of cancer immunotherapies. In this review, we describe the currently reported pathways and mechanisms involved in myeloid cell enhancement of the metastatic cascade.
Copyright © 2020 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 31548218      PMCID: PMC7197422          DOI: 10.1101/cshperspect.a038026

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  147 in total

1.  Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice.

Authors:  Jean Albrengues; Mario A Shields; David Ng; Chun Gwon Park; Alexandra Ambrico; Morgan E Poindexter; Priya Upadhyay; Dale L Uyeminami; Arnaud Pommier; Victoria Küttner; Emilis Bružas; Laura Maiorino; Carmelita Bautista; Ellese M Carmona; Phyllis A Gimotty; Douglas T Fearon; Kenneth Chang; Scott K Lyons; Kent E Pinkerton; Lloyd C Trotman; Michael S Goldberg; Johannes T-H Yeh; Mikala Egeblad
Journal:  Science       Date:  2018-09-28       Impact factor: 47.728

2.  Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice.

Authors:  Bastian Seubert; Barbara Grünwald; Julia Kobuch; Haissi Cui; Florian Schelter; Susanne Schaten; Jens T Siveke; Ngee H Lim; Hideaki Nagase; Nicole Simonavicius; Mathias Heikenwalder; Thomas Reinheckel; Jonathan P Sleeman; Klaus-Peter Janssen; Percy A Knolle; Achim Krüger
Journal:  Hepatology       Date:  2014-11-24       Impact factor: 17.425

3.  Neutrophils promote liver metastasis via Mac-1-mediated interactions with circulating tumor cells.

Authors:  Jonathan D Spicer; Braedon McDonald; Jonathan J Cools-Lartigue; Simon C Chow; Betty Giannias; Paul Kubes; Lorenzo E Ferri
Journal:  Cancer Res       Date:  2012-07-02       Impact factor: 12.701

Review 4.  Models, mechanisms and clinical evidence for cancer dormancy.

Authors:  Julio A Aguirre-Ghiso
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

Review 5.  Cathepsins mediate tumor metastasis.

Authors:  Gong-Jun Tan; Zheng-Ke Peng; Jin-Ping Lu; Fa-Qing Tang
Journal:  World J Biol Chem       Date:  2013-11-26

6.  Urokinase exerts antimetastatic effects by dissociating clusters of circulating tumor cells.

Authors:  Jin Woo Choi; Jun Ki Kim; Yun Jung Yang; Pilhan Kim; Kwon-Ha Yoon; Seok Hyun Yun
Journal:  Cancer Res       Date:  2015-11-01       Impact factor: 12.701

7.  Patrolling monocytes control tumor metastasis to the lung.

Authors:  Richard N Hanna; Caglar Cekic; Duygu Sag; Robert Tacke; Graham D Thomas; Heba Nowyhed; Erica Herrley; Nicole Rasquinha; Sara McArdle; Runpei Wu; Esther Peluso; Daniel Metzger; Hiroshi Ichinose; Iftach Shaked; Grzegorz Chodaczek; Subhra K Biswas; Catherine C Hedrick
Journal:  Science       Date:  2015-10-22       Impact factor: 47.728

8.  Targeting the ANG2/TIE2 axis inhibits tumor growth and metastasis by impairing angiogenesis and disabling rebounds of proangiogenic myeloid cells.

Authors:  Roberta Mazzieri; Ferdinando Pucci; Davide Moi; Erika Zonari; Anna Ranghetti; Alvise Berti; Letterio S Politi; Bernhard Gentner; Jeffrey L Brown; Luigi Naldini; Michele De Palma
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

Review 9.  Role of tumor associated macrophages in tumor angiogenesis and lymphangiogenesis.

Authors:  Vladimir Riabov; Alexandru Gudima; Nan Wang; Amanda Mickley; Alexander Orekhov; Julia Kzhyshkowska
Journal:  Front Physiol       Date:  2014-03-05       Impact factor: 4.566

10.  CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma.

Authors:  Colin W Steele; Saadia A Karim; Joshua D G Leach; Peter Bailey; Rosanna Upstill-Goddard; Loveena Rishi; Mona Foth; Sheila Bryson; Karen McDaid; Zena Wilson; Catherine Eberlein; Juliana B Candido; Mairi Clarke; Colin Nixon; John Connelly; Nigel Jamieson; C Ross Carter; Frances Balkwill; David K Chang; T R Jeffry Evans; Douglas Strathdee; Andrew V Biankin; Robert J B Nibbs; Simon T Barry; Owen J Sansom; Jennifer P Morton
Journal:  Cancer Cell       Date:  2016-06-02       Impact factor: 38.585

View more
  11 in total

1.  Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells.

Authors:  Silke Eisinger; Dhifaf Sarhan; Vanessa F Boura; Itziar Ibarlucea-Benitez; Sofia Tyystjärvi; Ganna Oliynyk; Marie Arsenian-Henriksson; David Lane; Stina L Wikström; Rolf Kiessling; Tommaso Virgilio; Santiago F Gonzalez; Dagmara Kaczynska; Shigeaki Kanatani; Evangelia Daskalaki; Craig E Wheelock; Saikiran Sedimbi; Benedict J Chambers; Jeffrey V Ravetch; Mikael C I Karlsson
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-23       Impact factor: 11.205

2.  MYC Levels Regulate Metastatic Heterogeneity in Pancreatic Adenocarcinoma.

Authors:  Ravikanth Maddipati; Robert J Norgard; Timour Baslan; Komal S Rathi; Amy Zhang; Asal Saeid; Taku Higashihara; Feng Wu; Angad Kumar; Valli Annamalai; Saurav Bhattacharya; Pichai Raman; Christian A Adkisson; Jason R Pitarresi; Maximilian D Wengyn; Taiji Yamazoe; Jinyang Li; David Balli; Michael J LaRiviere; Tuong-Vi C Ngo; Ian W Folkert; Ian D Millstein; Jonathan Bermeo; Erica L Carpenter; John C McAuliffe; Maja H Oktay; Rolf A Brekken; Scott W Lowe; Christine A Iacobuzio-Donahue; Faiyaz Notta; Ben Z Stanger
Journal:  Cancer Discov       Date:  2021-09-22       Impact factor: 38.272

3.  Emerging paradigms in metastasis research.

Authors:  Ashik Ahmed Abdul Pari; Mahak Singhal; Hellmut G Augustin
Journal:  J Exp Med       Date:  2021-01-04       Impact factor: 14.307

4.  Pharmacological inhibition of Mint3 attenuates tumour growth, metastasis, and endotoxic shock.

Authors:  Takeharu Sakamoto; Yuya Fukui; Yasumitsu Kondoh; Kaori Honda; Takeshi Shimizu; Toshiro Hara; Tetsuro Hayashi; Yurika Saitoh; Yoshinori Murakami; Jun-Ichiro Inoue; Shuichi Kaneko; Hiroyuki Osada; Motoharu Seiki
Journal:  Commun Biol       Date:  2021-10-07

5.  Identification of an Aptamer With Binding Specificity to Tumor-Homing Myeloid-Derived Suppressor Cells.

Authors:  Shaohui Tian; Thomas Welte; Junhua Mai; Yongbin Liu; Maricela Ramirez; Haifa Shen
Journal:  Front Pharmacol       Date:  2022-01-21       Impact factor: 5.988

Review 6.  Mini-Review: Can the Metastatic Cascade Be Inhibited by Targeting CD147/EMMPRIN to Prevent Tumor Recurrence?

Authors:  Michal A Rahat
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

Review 7.  Role of macrophages in tumor progression and therapy (Review).

Authors:  Yiwei Xu; Xiaomin Wang; Lijuan Liu; Jia Wang; Jibiao Wu; Changgang Sun
Journal:  Int J Oncol       Date:  2022-04-01       Impact factor: 5.650

8.  Unfolding innate mechanisms in the cancer microenvironment: The emerging role of the mesenchyme.

Authors:  Vasiliki Koliaraki; Ana Henriques; Alejandro Prados; George Kollias
Journal:  J Exp Med       Date:  2020-04-06       Impact factor: 14.307

Review 9.  The cell biology of inflammation: From common traits to remarkable immunological adaptations.

Authors:  Helen Weavers; Paul Martin
Journal:  J Cell Biol       Date:  2020-07-06       Impact factor: 10.539

Review 10.  Endogenous and Therapeutic Estrogens: Maestro Conductors of the Microenvironment of ER+ Breast Cancers.

Authors:  Linda A Schuler; Fern E Murdoch
Journal:  Cancers (Basel)       Date:  2021-07-24       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.